Global Nanotechnology Drug Delivery Market Size study & Forecast, by Technology by Application and Regional Analysis, 2023-2030

Description

List of Tables

Nanotechnology drugs enhance the targeted delivery of drugs to specific cells, tissues, or organs in the body. It involves the design, development, and utilization of nanoparticles or nanoscale materials to deliver therapeutic agents in a controlled manner. Nanotechnology drug delivery has the potential to revolutionize healthcare by improving the efficacy and safety of drug treatments. It is an active area of research and development, with numerous nanotechnology-based drug delivery systems being investigated for various diseases, including cancer, cardiovascular disorders, neurodegenerative diseases, and infectious diseases. The Nanotechnology Drug Delivery market is expanding because of factors such as the growing prevalence of cancer and genetic and cardiovascular diseases and growing preference for personalized medicines as well as the rising number of drug development activities across the world.

Demand for novel drugs with targeted delivery for various chronic diseases has increased primarily due to the rising prevalence of chronic diseases such as diabetes, cardiovascular, cancer disease. Diabetes is becoming more and more common among people worldwide. According to information from the International Diabetes Federation (IDF) Diabetes Atlas Tenth Edition 2021, 537 million persons (aged 20 to 79) were estimated to have diabetes in 2021. According to the same source, by 2030 there will be 643 million individuals worldwide living with diabetes, and by 2045 there will be 783 million. The demand for more technologically sophisticated drug delivery alternatives for treatment and diagnosis will undoubtedly rise as the prevalence of diabetes rises. In addition, the Global Cancer Observatory's (Globocan) Statistics 2020 report that there were 19.3 million new cases of cancer worldwide in 2020,. The same source notes that cancer is becoming more common worldwide and predicts that by 2040, there would be 28.8 million new instances of cancer in people of both sexes. As a result, the growing incidence of chronic diseases stimulates the demand for drug delivery systems based on nanotechnology, promoting market expansion. Furthermore, the expansion of the market has also been assisted by growing developments in nanoscale technologies and research & development efforts. In July 2022, for instance, the EU Horizon 2020 B-SMART project tried to develop a unique technique for delivering RNA past the blood-cerebrospinal fluid barrier, enabling therapies to be given directly to the brain. Therefore, developments in nano drug delivery systems fuel market expansion. Moreover, increasing advancements in nanoscale technologies, and a rising number of investments in research and development activities is creating new opportunities for the market. However, the high cost of nanotechnology drug delivery techniques and stringent regulations for commercial introduction stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Nanotechnology Drug Delivery Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to rising prevalence of various diseases, the presence of key market players, rising number of investments in research and development activities, rising number of clinical trials and drug discoveries activities in the region as well as rising demand for personalized medicine in the region.

Major market players included in this report are:

AbbVie Inc
Aquanova AG
BlueWillow Biologics
Bristol Myers Squibb (Celgene Inc)
Cytimmune Sciences Inc
NanoCarrier Co Ltd
NanOlogy LLC
Taiwan Liposome Co
Merck KGaA
Aphios Corporation

Recent Developments in the Market:

In June 2022, Researchers at the Baker Heart and Diabetes Institute created and developed a novel nanoparticle drug delivery system that can diagnose and treat several ailments as well as significantly increase the efficacy of a medication used to treat atherosclerosis.
In January 2022, Researchers at Case Western Reserve University developed nanoparticles that deliver clot-promoting enzymes to the bleeding site and then release them there to produce fibrin, the body's meshlike component that is essential for stopping the bleeding, where it is needed.

Global Nanotechnology Drug Delivery Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Technology, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

Nanocrystals
Nanoparticles
Liposomes
Micelles
Others

By Application:

Neurology
Oncology
Cardiovascular/Physiology
Anti-inflammatory/Immunology
Anti-infective
Other Applications

By Region:

North America

U.S.
Canada

Europe

UK
Germany
France
Spain
Italy
ROE

Asia Pacific

China
India
Japan
Australia
South Korea
RoAPAC

Latin America

Brazil
Mexico

Middle East & Africa

Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Nanotechnology Drug Delivery Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Nanotechnology Drug Delivery Market, by Technology, 2020-2030 (USD Billion)
- 1.2.3. Nanotechnology Drug Delivery Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Nanotechnology Drug Delivery Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Nanotechnology Drug Delivery Market Dynamics

3.1. Nanotechnology Drug Delivery Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Growing prevalence of cancer and genetic and cardiovascular diseases
  - 3.1.1.2. Growing preference for personalized medicines
  - 3.1.1.3. Rising number of drug development activities across the world.
- 3.1.2. Market Challenges
  - 3.1.2.1. High cost of nanotechnology drug delivery technique
  - 3.1.2.2. Stringent regulations for commercialization of product
- 3.1.3. Market Opportunities
  - 3.1.3.1. Growing developments in nanoscale technologies
  - 3.1.3.2. Rising investments for research and development

Chapter 4. Global Nanotechnology Drug Delivery Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Nanotechnology Drug Delivery Market, by Technology

5.1. Market Snapshot
5.2. Global Nanotechnology Drug Delivery Market by Technology, Performance - Potential Analysis
5.3. Global Nanotechnology Drug Delivery Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
5.4. Nanotechnology Drug Delivery Market, Sub Segment Analysis
- 5.4.1. Nanocrystals
- 5.4.2. Nanoparticles
- 5.4.3. Liposomes
- 5.4.4. Micelles
- 5.4.5. Others

Chapter 6. Global Nanotechnology Drug Delivery Market, by Application

6.1. Market Snapshot
6.2. Global Nanotechnology Drug Delivery Market by Application, Performance - Potential Analysis
6.3. Global Nanotechnology Drug Delivery Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Nanotechnology Drug Delivery Market, Sub Segment Analysis
- 6.4.1. Neurology
- 6.4.2. Oncology
- 6.4.3. Cardiovascular/Physiology
- 6.4.4. Anti-inflammatory/Immunology
- 6.4.5. Anti-infective
- 6.4.6. Other Applications

Chapter 7. Global Nanotechnology Drug Delivery Market, Regional Analysis

7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Nanotechnology Drug Delivery Market, Regional Market Snapshot
7.4. North America Nanotechnology Drug Delivery Market
- 7.4.1. U.S. Nanotechnology Drug Delivery Market
  - 7.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
  - 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
- 7.4.2. Canada Nanotechnology Drug Delivery Market
7.5. Europe Nanotechnology Drug Delivery Market Snapshot
- 7.5.1. U.K. Nanotechnology Drug Delivery Market
- 7.5.2. Germany Nanotechnology Drug Delivery Market
- 7.5.3. France Nanotechnology Drug Delivery Market
- 7.5.4. Spain Nanotechnology Drug Delivery Market
- 7.5.5. Italy Nanotechnology Drug Delivery Market
- 7.5.6. Rest of Europe Nanotechnology Drug Delivery Market
7.6. Asia-Pacific Nanotechnology Drug Delivery Market Snapshot
- 7.6.1. China Nanotechnology Drug Delivery Market
- 7.6.2. India Nanotechnology Drug Delivery Market
- 7.6.3. Japan Nanotechnology Drug Delivery Market
- 7.6.4. Australia Nanotechnology Drug Delivery Market
- 7.6.5. South Korea Nanotechnology Drug Delivery Market
- 7.6.6. Rest of Asia Pacific Nanotechnology Drug Delivery Market
7.7. Latin America Nanotechnology Drug Delivery Market Snapshot
- 7.7.1. Brazil Nanotechnology Drug Delivery Market
- 7.7.2. Mexico Nanotechnology Drug Delivery Market
7.8. Middle East & Africa Nanotechnology Drug Delivery Market
- 7.8.1. Saudi Arabia Nanotechnology Drug Delivery Market
- 7.8.2. South Africa Nanotechnology Drug Delivery Market
- 7.8.3. Rest of Middle East & Africa Nanotechnology Drug Delivery Market

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
- 8.1.1. Company 1
- 8.1.2. Company 2
- 8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. AbbVie Inc
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Recent Developments
- 8.3.2. Aquanova AG
- 8.3.3. BlueWillow Biologics
- 8.3.4. Bristol Myers Squibb (Celgene Inc)
- 8.3.5. Cytimmune Sciences Inc
- 8.3.6. NanoCarrier Co Ltd
- 8.3.7. NanOlogy LLC
- 8.3.8. Taiwan Liposome Co
- 8.3.9. Merck KGaA
- 8.3.10. Aphios Corporation

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Nanotechnology Drug Delivery Market, report scope
TABLE 2. Global Nanotechnology Drug Delivery Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Nanotechnology Drug Delivery Market estimates & forecasts by Technology 2020-2030 (USD Billion)
TABLE 4. Global Nanotechnology Drug Delivery Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Nanotechnology Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Nanotechnology Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Nanotechnology Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Nanotechnology Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Nanotechnology Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Nanotechnology Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Nanotechnology Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Nanotechnology Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Nanotechnology Drug Delivery Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Nanotechnology Drug Delivery Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Nanotechnology Drug Delivery Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Nanotechnology Drug Delivery Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Nanotechnology Drug Delivery Market
TABLE 70. List of primary sources, used in the study of global Nanotechnology Drug Delivery Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Nanotechnology Drug Delivery Market, research methodology
FIG 2. Global Nanotechnology Drug Delivery Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Nanotechnology Drug Delivery Market, key trends 2022
FIG 5. Global Nanotechnology Drug Delivery Market, growth prospects 2023-2030
FIG 6. Global Nanotechnology Drug Delivery Market, porters 5 force model
FIG 7. Global Nanotechnology Drug Delivery Market, pest analysis
FIG 8. Global Nanotechnology Drug Delivery Market, value chain analysis
FIG 9. Global Nanotechnology Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Nanotechnology Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Nanotechnology Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Nanotechnology Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Nanotechnology Drug Delivery Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Nanotechnology Drug Delivery Market, regional snapshot 2020 & 2030
FIG 15. North America Nanotechnology Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 16. Europe Nanotechnology Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Nanotechnology Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Nanotechnology Drug Delivery Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Nanotechnology Drug Delivery Market 2020 & 2030 (USD Billion)